TDF Combined With LDT for the Treatment of HBeAg-positive Hepatitis B Patients With Poor Response to TDF for 12 Months

NCT04650828 · clinicaltrials.gov ↗

UNKNOWN

Status

200

Enrollment

OTHER

Sponsor class

Conditions

Chronic Hepatitis B

Interventions

DRUG: TDF
DRUG: Tenofovir Disoproxil Fumarate 300 MG

Sponsor

Third Affiliated Hospital, Sun Yat-Sen University